Angiopoietin-like protein 2 negatively regulated by microRNA-25 contributes to the malignant progression of colorectal cancer

International Journal of Molecular Medicine

Volumn 34, Issue 5, 2014, Pages 1286-1292

  Zhou, Jumei ^a   Wang, Jing ^a   Wu, Shengqi ^a   Zhu, Suyu ^a   Wang, Sai ^a   Zhou, Huijun ^a   Tian, Xiaoqing ^a   Tang, Ning ^a   Nie, Shaolin ^a  

^a Central South University   (China)

Author keywords

Angiopoietin like protein 2; Colorectal cancer; Metastasis; MicroRNA 25

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE PROTEIN 2; MESSENGER RNA; MICRORNA; MICRORNA 25; UNCLASSIFIED DRUG; ANGPTL2 PROTEIN, HUMAN; MIRN25 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; CANCER GROWTH; CELL INVASION; CELL MIGRATION; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC REGULATION; HCT116 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; PROTEIN BINDING; UPREGULATION; CELL MOTION; COLORECTAL NEOPLASMS; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANGIOPOIETINS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DOWN-REGULATION; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; MICRORNAS; RNA, MESSENGER; UP-REGULATION;

EID: 84907220181     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1909     Document Type: Article

References (39)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
3. Suda T, Arai F and Shimmura S: Regulation of stem cells in the niche. Cornea 24: S12-S17, 2005.
4. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ and Holash J: Vascular-specific growth factors and blood vessel formation. Nature 407: 242-248, 2000.
5. Hato T, Tabata M and Oike Y: The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc Med 18: 6-14, 2008.
6. Tabata M, Kadomatsu T, Fukuhara S, et al: Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab 10: 178-188, 2009.
7. Tazume H, Miyata K, Tian Z, et al: Macrophage-derived angiopoietin-like protein 2 accelerates development of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 32: 1400-1409, 2012.
8. Okada T, Tsukano H, Endo M, et al: Synoviocyte-derived angiopoietin-like protein 2 contributes to synovial chronic inflammation in rheumatoid arthritis. Am J Pathol 176: 2309-2319, 2010.
9. Aoi J, Endo M, Kadomatsu T, et al: Angiopoietin-like protein 2 is an important facilitator of inflammatory carcinogenesis and metastasis. Cancer Res 71: 7502-7512, 2011.
10. Endo M, Nakano M, Kadomatsu T, et al: Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis. Cancer Res 72: 1784-1794, 2012.
11. Sasaki H, Suzuki A, Shitara M, et al: Angiopoietin-like protein ANGPTL2 gene expression is correlated with lymph node metastasis in lung cancer. Oncol Lett 4: 1325-1328, 2012.
12. Kikuchi R, Tsuda H, Kozaki K, et al: Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer. Cancer Res 68: 5067-5075, 2008.
13. Schetter AJ and Harris CC: Alterations of microRNAs contribute to colon carcinogenesis. Semin Oncol 38: 734-742, 2011.
14. Wu WK, Law PT, Lee CW, et al: MicroRNA in colorectal cancer: from benchtop to bedside. Carcinogenesis 32: 247-253, 2011.
15. Li Q, Zou C, Zou C, et al: MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7. Cancer Lett 335: 168-174, 2013.
16. Arocho A, Chen B, Ladanyi M and Pan Q: Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts. Diagn Mol Pathol 15: 56-61, 2006.
17. Jiang X, Yue J, Lu H, et al: Inhibition of filamin-A reduces cancer metastatic potential. Int J Biol Sci 9: 67-77, 2013.
18. Aspenström P, Fransson A and Saras J: Rho GTPases have diverse effects on the organization of the actin filament system. Biochem J 377: 327-337, 2004.
19. Saadoun S, Papadopoulos MC, Hara-Chikuma M and Verkman AS: Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption. Nature 434: 786-792, 2005.
20. Lai AZ, Durrant M, Zuo D, Ratcliffe CD and Park M: Met kinase-dependent loss of the E3 ligase Cbl in gastric cancer. J Biol Chem 287: 8048-8059, 2012.
21. Baldwin A, Huh KW and Munger K: Human papillomavirus E7 oncoprotein dysregulates steroid receptor coactivator 1 localization and function. J Virol 80: 6669-6677, 2006.
22. Hill R, Calvopina JH, Kim C, et al: PTEN loss accelerates KrasG12D-induced pancreatic cancer development. Cancer Res 70: 7114-7124, 2010.
23. Woods NT, Yamaguchi H, Lee FY, Bhalla KN and Wang HG: Anoikis, initiated by Mcl-1 degradation and Bim induction, is deregulated during oncogenesis. Cancer Res 67: 10744-10752, 2007.
24. Kadera BE, Li L, Toste PA, et al: MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis. PLoS One 8: e71978, 2013.
25. Dahlhaus M, Schult C, Lange S, Freund M and Junghanss C: MicroRNA 181a influences the expression of HMGB1 and CD4 in acute Leukemias. Anticancer Res 33: 445-452, 2013.
26. Sandhu R, Rivenbark AG and Coleman WB: Loss of post-transcriptional regulation of DNMT3b by microRNAs: A possible molecular mechanism for the hypermethylation defect observed in a subset of breast cancer cell lines. Int J Oncol 41: 721-732, 2012.
27. Fang JY, Lu J, Chen YX and Yang L: Effects of DNA methylation on expression of tumor suppressor genes and proto-oncogene in human colon cancer cell lines. World J Gastroenterol 9: 1976-1980, 2003.
28. Pakneshan P, Szyf M and Rabbani SA: Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells. Carcinogenesis 26: 557-564, 2005.
29. Chien CH and Chow SN: Point mutation of the ras oncogene in human ovarian cancer. DNA Cell Biol 12: 623-627, 1993.
30. Beger M, Butz K, Denk C, Williams T, Hurst HC and Hoppe-Seyler F: Expression pattern of AP-2 transcription factors in cervical cancer cells and analysis of their influence on human papillomavirus oncogene transcription. J Mol Med (Berl) 79: 314-320, 2001.
31. Patel JB, Appaiah HN, Burnett RM, et al: Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22. Oncogene 30: 1290-1301, 2011.
32. Shenouda SK and Alahari SK: MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev 28: 369-378, 2009.
33. Lukiw WJ and Alexandrov PN: Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain. Mol Neurobiol 46: 11-19, 2012.
34. Esposito F, Tornincasa M, Pallante P, et al: Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2. J Clin Endocrinol Metab 97: E710-E718, 2012.
35. Razumilava N, Bronk SF, Smoot RL, et al: miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma. Hepatology 55: 465-475, 2012.
36. Zhang H, Zuo Z, Lu X, Wang L, Wang H and Zhu Z: miR-25 regulates apoptosis by targeting Bim in human ovarian cancer. Oncol Rep 27: 594-598, 2012.
37. Rodríguez-Aznar E, Barrallo-Gimeno A and Nieto MA: Scratch2 prevents cell cycle re-entry by repressing miR-25 in postmitotic primary neurons. J Neurosci 33: 5095-5105, 2013.
38. Lu D, Davis MP, Abreu-Goodger C, et al: miR-25 regulates Wwp2 and Fbxw7 and promotes reprogramming of mouse fibroblast cells to iPSCs. PLoS One 7: e40938, 2012.
39. Zhu Z, He J, Jia X, et al: MicroRNA-25 functions in regulation of pigmentation by targeting the transcription factor MITF in alpaca (Lama pacos) skin melanocytes. Domest Anim Endocrinol 38: 200-209, 2010.